Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2160536rdf:typepubmed:Citationlld:pubmed
pubmed-article:2160536lifeskim:mentionsumls-concept:C0003015lld:lifeskim
pubmed-article:2160536lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:2160536lifeskim:mentionsumls-concept:C0038760lld:lifeskim
pubmed-article:2160536lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:2160536lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:2160536lifeskim:mentionsumls-concept:C0051083lld:lifeskim
pubmed-article:2160536lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:2160536pubmed:issue6lld:pubmed
pubmed-article:2160536pubmed:dateCreated1990-6-28lld:pubmed
pubmed-article:2160536pubmed:abstractTextCompounds 1a-g consisting of enalaprilat covalently bonded to aryl sulfonamides, including several known thiazide diuretics, were synthesized and tested for ACE inhibitory and diuretic and overall antihypertensive effects. All compounds were potent ACE inhibitors in vitro, with IC50 = 6.5-85 nM. At 10 mg/kg iv or ip in the rat, 1a-g inhibited the AI pressor response by 76-100%; inhibition declined significantly upon oral dosing. Compounds 1a and 1f at 100 mg/kg ip in the sodium-depleted, spontaneously hypertensive rats reduced blood pressure 28-35% and 41-42%, respectively. Compounds 1a and 1f elicited natriuresis and kaliuresis without accompanying volume increases in the rat; 1c at 25 mg/kg iv induced delayed diuresis. Compound 1f has been chosen for further development.lld:pubmed
pubmed-article:2160536pubmed:languageenglld:pubmed
pubmed-article:2160536pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:citationSubsetIMlld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2160536pubmed:statusMEDLINElld:pubmed
pubmed-article:2160536pubmed:monthJunlld:pubmed
pubmed-article:2160536pubmed:issn0022-2623lld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:BartonJJlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:NeissE SESlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:SuhJ TJTlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:SchwabAAlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:BrunoJ GJGlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:KornbergB EBElld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:ReganJ RJRlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:MencelJ JJJlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:MenardP RPRlld:pubmed
pubmed-article:2160536pubmed:authorpubmed-author:CalvoR RRRlld:pubmed
pubmed-article:2160536pubmed:issnTypePrintlld:pubmed
pubmed-article:2160536pubmed:volume33lld:pubmed
pubmed-article:2160536pubmed:ownerNLMlld:pubmed
pubmed-article:2160536pubmed:authorsCompleteYlld:pubmed
pubmed-article:2160536pubmed:pagination1606-15lld:pubmed
pubmed-article:2160536pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:meshHeadingpubmed-meshheading:2160536-...lld:pubmed
pubmed-article:2160536pubmed:year1990lld:pubmed
pubmed-article:2160536pubmed:articleTitleAngiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives.lld:pubmed
pubmed-article:2160536pubmed:affiliationRorer Central Research, King of Prussia, Pennsylvania 19406.lld:pubmed
pubmed-article:2160536pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2160536lld:chembl